News Focus
News Focus
Followers 590
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: dr_lowenstein post# 21607

Tuesday, 07/17/2012 11:42:20 AM

Tuesday, July 17, 2012 11:42:20 AM

Post# of 445817
Seems you still don't understand the smarts of a Jerry Treppel.

When Jerry Treppel has completed the deal with the Pharma, then there will be a PR and then there will be a lot of pain with a "Short Squeeze" !!!

Meanwhile the 10-K is crystal clear as is removal of the B &C preferreds.

In case there is a problem connecting the dots.




###

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77572052


Elite is converting the B & C to Common shs to get rid of the Preferreds. Elite is moving from a position of strength so that the next deal is a Pharma deal as I previously posted.

Third Party Funding for ELI-154 and ELI-216


Elite has developed ELI-154 and ELI-216 and retains the rights to these products. Elite has chosen to develop these products itself but expects to license these products at a later date to a third party who could provide funding for the remaining clinical studies, including a Phase III study, and who could provide sales and distribution for the product.


Page 11 & 12

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8346235

How about more like this as a speculation?

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76918558
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News